Application of penehyclidine hydrochloride in preparing medicament for treating cardiogenic shock
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHENGDU LIST PHARMA
- Publication Date
- 2009-07-08
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medicines, in particular to the new medical application of penehyclidine hydrochloride, in particular to the application of penehyclidine hydrochloride in the preparation of medicines for treating cardiogenic shock diseases. The pathological changes of the cardiogenic shock are as follows: the systolic blood pressure and the mean arterial pressure drop by at least 40%, the maximum rate of increase in the left ventricular pressure (LV+dp / dt max ) decreased by at least 80%, and cardiac output decreased by at least 40%. Background technique
[0002] Penehyclidine hydrochloride, English name Penehyclidine Hydrochloride, chemical name 3-(2-cyclopentyl-2-hydroxy-2-phenylethoxy)quinuclidine hydrochloride, molecular formula C 20 h 29 NO 2 • HCl, molecular weight 351.92.
[0003] Penehyclidine hydrochloride is a new type of anticholinergic drug with selective M 1 , M 3 and N 1 , N 2 Receptor antagonism, has a strong...